Overview

Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections

Status:
Completed
Trial end date:
2016-10-28
Target enrollment:
Participant gender:
Summary
The aim of this study is to see the efficacy and safety of BAY1192631 in Japanese patients with methicillin-resistant staphylococcus aureus (MRSA) (skin and soft tissue infections (SSTI) and SSTI-related bacteremia).
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Linezolid
Methicillin
Tedizolid
Tedizolid phosphate
Torezolid